AARDVARK THERAPEUTICS INC
AARD·002942100·US·Common Stock·Healthcare - Biotechnology-13D/G
AARD (AARDVARK THERAPEUTICS INC) is held by 52 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($4.7M), BlackRock, Inc. ($3M), VANGUARD CAPITAL MANAGEMENT LLC ($2.1M). Net institutional sentiment: Mixed.
52
Holders
(4 Elite)
$18.1M
Total Value
51% (57)
Consensus
29 buying - 28 selling
13F: Insider & Congress:
Who's Trading
InsiderLTLee Tien-LiBuy $101KDec 11, 2025
InsiderSNSun NelsonBuy $43KDec 11, 2025
InsiderLTLee Tien-LiBuy $35KSep 15, 2025
InsiderLTLee Tien-LiBuy $62KSep 15, 2025
InsiderLTLee Tien-LiBuy $43KSep 12, 2025
InsiderLTLee Tien-LiBuy $47KSep 11, 2025
InsiderLTLee Tien-LiBuy $71KSep 10, 2025
InsiderSNSun NelsonBuy $48KSep 9, 2025
ActivistTLTien-Li Lee13.7%May 15, 2025
Showing 1-20 of 60
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer